( en | de | ru )

 

Disambiguation of "Glynn, Robert J."

Author of the publication

copydeleteadd this publication to your clipboard
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

, , , , , , , , , , , , , , , , , , , , , , , , , , , and . N Engl J Med, 377 (12): 1119--1131 (Aug 27, 2017)
DOI: 10.1056/nejmoa1707914

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Glynn Meter

Robert J Schuldt

Robert J Gdanitz

Robert J Zydenbos

Robert J Foster

 

Other publications of authors with the same name

The Wilcoxon signed rank test for paired comparisons of clustered data., , and . Biometrics, 62 (1): 185-92 (March 2006)4150<m:linebreak></m:linebreak>LR: 20061115; PUBM: Print; GR: EY 12269/EY/NEI; JID: 0370625; 1406-18-4 (Vitamin E); ppublish;<m:linebreak></m:linebreak>Dissenys de cluster.Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect., , , , , , and . American journal of epidemiology, 163 (3): 262-70 (February 2006)One-to-many propensity score matching in cohort studies., , , , , and . Pharmacoepidemiology and drug safety, (May 2012)Propensity score.Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy., , , , , , and . Pharmacoepidemiology and drug safety, 22 (8): 810-8 (August 2013)Propensity score; Oncologia.Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses, , , , , , , , , and 17 other author(s). 329 (16): 1376 (2023)Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information., , , , and . Medical care, 45 (10 Supl 2): S158-65 (October 2007)6354<m:linebreak></m:linebreak>LR: 20091118; GR: R01 023178/PHS HHS/United States; GR: R01 AG023178-03/AG/NIA NIH HHS/United States; JID: 0230027; 0 (Anti-Inflammatory Agents, Non-Steroidal); RF: 46; NIHMS40822; OID: NLM: NIHMS40822; OID: NLM: PMC2265540; ppublish;<m:linebreak></m:linebreak>CER.Evaluation of a mandatory phishing training program for high-risk employees at a US healthcare system., , , , , , and . J. Am. Medical Informatics Assoc., 26 (6): 547-552 (2019)Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study., , , and . American journal of epidemiology, 172 (7): 843-54 (October 2010)5732<m:linebreak></m:linebreak>JID: 7910653; aheadofprint;<m:linebreak></m:linebreak>Propensity score.Role of disease risk scores in comparative effectiveness research with emerging therapies., , and . Pharmacoepidemiology and drug safety, (May 2012)Propensity score; Disease risk score; CER.Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease, , , , , , , , , and 18 other author(s). N Engl J Med, 377 (12): 1119--1131 (Aug 27, 2017)